Delayed ageing through damage protection by the Arf/p53 pathway

Nature

Volumn 448, Issue 7151, 2007, Pages 375-379

  Matheu, Ander ^a,d   Maraver, Antonio ^a   Klatt, Peter ^a   Flores, Ignacio ^a   Garcia Cao, Isabel ^a   Borras, Consuelo ^b,e   Flores, Juana M ^c   Viña, Jose ^b   Blasco, Maria A ^a   Serrano, Manuel ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^e UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; PROTEIN P53;

AGING; CANCER; DAMAGE; DISEASE RESISTANCE; GENETIC ENGINEERING; PROTEOMICS; TUMOR;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER PREVENTION; CANCER RESISTANCE; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; GENETIC REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

MUS;

EID: 34447517413     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05949     Document Type: Article

References (38)

1. Harris, S. L. & Levine, A. J. The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899-2908 (2005).
2. Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315 (2004).
3. Pinkston, J. M., Garigan, D., Hansen, M. & Kenyon, C. Mutations that increase the life span of C. elegans inhibit tumor growth. Science 313, 971-975 (2006).
4. Garcia-Cao, I. et al. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21, 6225-6235 (2002).
5. Matheu, A. et al. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev. 18, 2736-2746 (2004).
6. Garcia-Cao, I. et al. Increased p53 activity does not accelerate telomere-driven ageing. EMBO Rep. 7, 546-552 (2006).
7. Mendrysa, S. M. et al. Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev. 20, 16-21 (2006).
8. Tyner, S. D. et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45-53 (2002).
9. Maier, B. et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306-319 (2004).
10. Forster, M. J., Morris, P. & Sohal, R. S. Genotype and age influence the effect of caloric intake on mortality in mice. FASEB J. 17, 690-692 (2003).
11. Liang, H. et al. Genetic mouse models of extended lifespan. Exp. Gerontol. 38, 1353-1364 (2003).
12. Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799-3810 (2003).
13. Ingram, D. K. & Reynolds, M. A. Assessing the predictive validity of psychomotor tests as measures of biological age in mice. Exp. Aging Res. 12, 155-162 (1986).
14. Sedelnikova, O. A. et al. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell Biol. 6, 168-170 (2004).
15. Herbig, U., Ferreira, M., Condel, L., Carey, D. & Sedivy, J. M. Cellular senescence in aging primates. Science 311, 1257 (2006).
16. Janzen, V. et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 443, 421-426 (2006).
17. Krishnamurthy, J. et al. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443, 453-457 (2006).
18. Molofsky, A. V. et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443, 448-452 (2006).
19. Schriner, S. E. et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308, 1909-1911 (2005).
20. Vousden, K. H. & Lane, D. P. p53 in health and disease. Nature Rev. Mol. Cell Biol. 8, 275-283 (2007).
21. Velasco-Miguel, S. et al. PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes. Oncogene 18, 127-137 (1999).
22. Budanov, A. V. et al. Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene 21, 6017-6031 (2002).
23. Sablina, A. A. et al. The antioxidant function of the p53 tumor suppressor. Nature Med. 11, 1306-1313 (2005).
24. Neumann, C. A. et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424, 561-565 (2003).
25. Wood, Z. A., Schroder, E., Robin Harris, J. & Poole, L. B. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 28, 32-40 (2003).
26. Budanov, A. V., Sablina, A. A., Feinstein, E., Koonin, E. V. & Chumakov, P. M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596-600 (2004).
27. Agarwal, S. & Sohal, R. S. Relationship between susceptibility to protein oxidation, aging, and maximum life span potential of different species. Exp. Gerontol. 31, 365-372 (1996).
28. Kapahi, P., Boulton, M. E. & Kirkwood, T. B. Positive correlation between mammalian life span and cellular resistance to stress. Free Radic. Biol. Med. 26, 495-500 (1999).
29. Yamamoto, M. et al. Regulation of oxidative stress by the anti-aging hormone klotho. J. Biol. Chem. 280, 38029-38034 (2005).
30. Varela, I. et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437, 564-568 (2005).
31. Pantoja, C. & Serrano, M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18, 4974-4982 (1999).
32. Palmero, I. & Serrano, M. Induction of senescence by oncogenic Ras. Methods Enzymol. 333, 247-256 (2001).
33. Wexler, H. & Rosenberg, S. A. Pulmonary metastases from autochthonous 3-methylcholanthrene-induced murine tumors. J. Natl Cancer Inst. 63, 1393-1395 (1979).
34. Matheu, A., Klatt, P. & Serrano, M. Regulation of the INK4a/ARF locus by histone deacetylase inhibitors. J. Biol. Chem. 280, 42433-42441 (2005).
35. Yuan, J. S., Reed, A., Chen, F. & Stewart, C. N. Jr Statistical analysis of real-time PCR data. BMC Bioinformatics 7, 85 (2006).
36. Asensi, M., Sastre, J., Pallardo, F. V., Estrela, J. M. & Vina, J. Determination of oxidized glutathione in blood: high-performance liquid chromatography. Methods Enzymol. 234, 367-371 (1994).
37. Wong, S. H. et al. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin. Chem. 33, 214-220 (1987).
38. Gonzalez-Suarez, E., Samper, E., Flores, J. M. & Blasco, M. A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nature Genet. 26, 114-117 (2000).